Acadia Healthcare (NASDAQ:ACHC) Shares Gap Down Following Analyst Downgrade

Acadia Healthcare Company, Inc. (NASDAQ:ACHC)’s share price gapped down prior to trading on Thursday after StockNews.com downgraded the stock from a hold rating to a sell rating. The stock had previously closed at $72.99, but opened at $70.14. Acadia Healthcare shares last traded at $69.04, with a volume of 323,695 shares trading hands.

A number of other analysts have also recently commented on ACHC. Deutsche Bank Aktiengesellschaft upgraded Acadia Healthcare from a “sell” rating to a “hold” rating and set a $70.00 price objective for the company in a research report on Thursday, April 25th. Barclays cut their price target on shares of Acadia Healthcare from $100.00 to $91.00 and set an “overweight” rating for the company in a report on Thursday. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $90.00 price objective on shares of Acadia Healthcare in a report on Tuesday, March 5th. Stephens raised shares of Acadia Healthcare from an “equal weight” rating to an “overweight” rating and set a $92.00 target price for the company in a research note on Friday, January 5th. Finally, UBS Group upped their price target on shares of Acadia Healthcare from $88.00 to $102.00 and gave the stock a “buy” rating in a research report on Wednesday, February 28th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and six have issued a buy rating to the company’s stock. According to data from MarketBeat, Acadia Healthcare currently has a consensus rating of “Moderate Buy” and a consensus target price of $89.50.

Insider Buying and Selling

In other Acadia Healthcare news, Director Wade D. Miquelon sold 2,203 shares of the stock in a transaction dated Tuesday, March 5th. The shares were sold at an average price of $85.39, for a total value of $188,114.17. Following the completion of the sale, the director now owns 46,074 shares in the company, valued at approximately $3,934,258.86. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 2.00% of the stock is currently owned by company insiders.

Institutional Trading of Acadia Healthcare

Large investors have recently added to or reduced their stakes in the stock. Headlands Technologies LLC purchased a new position in shares of Acadia Healthcare during the 3rd quarter worth $25,000. GAMMA Investing LLC purchased a new position in Acadia Healthcare during the fourth quarter worth about $26,000. Mather Group LLC. acquired a new position in Acadia Healthcare in the 1st quarter valued at about $48,000. Fifth Third Bancorp grew its stake in shares of Acadia Healthcare by 25.5% in the 4th quarter. Fifth Third Bancorp now owns 670 shares of the company’s stock valued at $52,000 after buying an additional 136 shares during the period. Finally, DekaBank Deutsche Girozentrale acquired a new stake in shares of Acadia Healthcare during the 3rd quarter worth approximately $96,000.

Acadia Healthcare Price Performance

The firm has a market cap of $6.11 billion, a price-to-earnings ratio of -472.29, a P/E/G ratio of 2.15 and a beta of 1.31. The stock’s fifty day moving average price is $77.13 and its 200-day moving average price is $77.61. The company has a current ratio of 0.67, a quick ratio of 0.67 and a debt-to-equity ratio of 0.48.

Acadia Healthcare (NASDAQ:ACHC) last posted its earnings results on Wednesday, May 1st. The company reported $0.84 EPS for the quarter, beating analysts’ consensus estimates of $0.80 by $0.04. The company had revenue of $768.10 million for the quarter, compared to the consensus estimate of $779.20 million. Acadia Healthcare had a positive return on equity of 11.56% and a negative net margin of 0.38%. The company’s revenue for the quarter was up 9.1% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.75 earnings per share. As a group, equities research analysts forecast that Acadia Healthcare Company, Inc. will post 3.57 earnings per share for the current fiscal year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.